KeyBanc Downgrades DaVita To Hold
September 17, 2014 at 08:12 AM EDT
Analysts at KeyBanc downgraded DaVita HealthCare Partners (NYSE: DVA) from Buy to Hold and removed the target price of $75. DaVita ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.